Slide background Managed Access Program

Helping patients who exhausted all treatment options

Find Out More
Slide background RLD sourcing

Trusted partner for sourcing Reference Listed Drugs

Find Out More
Slide background Clinical trial materials supply

Building Capabilities

Find Out More
Slide background Good Distribution Practices

Certified distribution practices

Find Out More

What We Provide

Ikris Pharma International facilitates patients in accessing medicines and other pharmaceutical products unavailable in their home country against valid prescriptions in conformity with all local laws and regulations. Read More

Managed Access Program

We develop ethical and regulatory compliant strategic solutions for pharmaceutical and biotechnology companies enabling a fast...

Read More

RLD Sourcing

Specialized in sourcing branded Innovator Samples/Reference Listed Drugs (RLD) from single/multiple batches...

Read More

Clinical Trial Materials Supply

Sourcing and supply of commercial medicines / comparators for clinical trials study across all therapeutic...

Read More

Good Distribution Practices

GDP of medicines are designed to allow that a high level of quality is maintained throughout the drug distribution network....

Read More

Ikris Pharma International

Ikris Pharma International is a global service provider offering accessibility to a wide range of pharmaceutical products to the patients, distributors and healthcare sector. We are amongst the leading pharmaceutical wholesalers in Belgium having a wide network to supply specialty medicines across the globe under compliant regulations. As a distributor of pharmaceuticals our highest priority is to maintain high quality standards throughout the supply chain. Our processes and procedures are executed under the EU guidelines on Good Distribution Practices of medicinal products for the human use. Besides that, providing consistent customer services and maintaining client anonymity are amongst our other top priorities.
By securing medicines through authentic sources, we contribute to the safety and reliability for the patients needing such medicines.